EX-1 2 v012552_ex-1.txt Exhibit 1 Joint Filing Agreement This will confirm the agreement as of February 8, 2005 by and among all the undersigned that the Statement on Schedule 13G filed on or about this date and any further amendments thereto with respect to beneficial ownership by the undersigned of the shares of the common stock, $.001 par value per share, of Immunicon Corporation, a Delaware corporation, is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934. The undersigned further agree that each party hereto is responsible for timely filing of such Statement on Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, provided that no party is responsible for the completeness and accuracy of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate. The undersigned further agree that this agreement shall be included as an Exhibit to such joint filing. This agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. MDS Capital Corp. By: /s/ Gregory Gubitz By: /s/ Graysanne Bedell ---------------------------- ----------------------- Name: Gregory Gubitz Name: Graysanne Bedell Title: Chief Operating Officer Title: Vice-President - Legal and Secretary -2- MDS Life Sciences Technology Fund Limited Partnership By: MDS Life Sciences Technology Fund (GP) Inc. By: /s/ Gregory Gubitz By: /s/ Graysanne Bedell ---------------------------- ----------------------- Name: Gregory Gubitz Name: Graysanne Bedell Title: Vice-President Title: Secretary MDS Life Sciences Technology Fund USA, L.P. By: MDS Capital USA (GP) Inc. By: /s/ Gregory Gubitz By: /s/ Michael Mueller ---------------------------- ----------------------- Name: Gregory Gubitz Name: Michael Mueller Title: Vice-President Title: President -3- MDS Life Sciences Technology Barbados Investment Trust By: By: /s/ Gillian Jordan ---------------------------- Name: Gillian Jordan Title: Trustee SC Biotechnology Development Fund LP By: SC (GP) Inc., its General Partner By: /s/ John Ackerley By: /s/ William Walmsely ---------------------------- ----------------------- Name: John Ackerley Name: William Walmsley Title: Directors of Cardinal Title: Director of Cardinal Investments Limited Investments Limited (Director of SC (Director of SC (GP) Inc.) (GP) Inc.) MDS Life Sciences Technology Fund (GP) Inc. By: /s/ Gregory Gubitz By: /s/ Graysanne Bedell ---------------------------- ----------------------- Name: Gregory Gubitz Name: Graysanne Bedell Title: Vice-President Title: Secretary -4- MDS Capital USA (GP) Inc. By: /s/ Gregory Gubitz By: /s/ Michael Mueller ---------------------------- ----------------------- Name: Gregory Gubitz Name: Michael Mueller Title: Vice-President Title: President SC (GP) Inc. By: /s/ John Ackerley By: /s/ William Walmsely ---------------------------- ----------------------- Name: John Ackerley Name: William Walmsley Title: Directors of Cardinal Title: Director of Cardinal Investments Limited Investments Limited (Director of SC (Director of SC (GP) Inc.) (GP) Inc.) MDS Capital Management Corp. By: /s/ Gregory Gubitz By: /s/ Graysanne Bedell ---------------------------- ----------------------- Name: Gregory Gubitz Name: Graysanne Bedell Title: Chief Operating Officer Title: Vice-President - Legal and Secretary